# The Effects of Acetylsalicylic Acid on Immunoparalysis Following Human Endotoxemia

> **NCT02922673** · NA · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Endotoxemia

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02922673
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2016-12
- **Final completion:** 2017-09
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2019-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02922673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02922673, "The Effects of Acetylsalicylic Acid on Immunoparalysis Following Human Endotoxemia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02922673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*